As the battle against obesity and diabetes heats up, two new superstars are entering the ring in Spain - Mounjaro (also known ...

Wegovy is already available in five other European countries, including Norway, Spain, Switzerland, Italy, and Iceland. However, increasing access to Wegovy elsewhere in Europe has been slow going ...

The IMF’s latest report put Spain ahead of the UK (1.1 per cent), France (1.1 per cent), Italy (0.7 per cent) and Germany ...

Novo Nordisk, the company behind Ozempic and Wegovy, is now Europe's largest company as global demand for its drugs have soared. But the Danish pharmaceutical company's origins were motivated by ...

“Keep [the drug] for those that need it most,” Collins said. Wegovy is also available in Norway, Spain, Switzerland, Italy, ...

European shares ended lower on Wednesday, following a broad rally earlier in the session, hurt by a drop in utilities shares ...

Wegovy is a weight loss medication that you can only get with a prescription from a licensed healthcare professional. Learn more about who is eligible and what to expect at your initial ...

The diabetes and weight loss medications Ozempic and Wegovy are now considered to be available after more than two years of being considered in shortage by the Food and Drug Administration (FDA).

The demand for weight loss operations dropped sharply last year as the number of people opting for anti-obesity drugs such as Wegovy and Saxenda more than doubled, a study published Friday found.

Few things have stirred up as much commotion in either the weight loss or pharmaceutical world as Ozempic and Wegovy. There's a good reason for that — these drugs have proven to be highly ...

Ozempic (semaglutide) and Wegovy (semaglutide) are prescription drugs that may be used to help with long-term weight loss. But only Wegovy is FDA-approved for this use. Both drugs are approved for ...

Global markets advanced, with interest rate-sensitive sectors leading due to changes in monetary conditions; US and European ...